105 related articles for article (PubMed ID: 18032924)
1. Suppression of TGF-beta signaling by phospholipase D.
Gadir N; Lee E; Garcia A; Toschi A; Foster DA
Cell Cycle; 2007 Nov; 6(22):2840-5. PubMed ID: 18032924
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase D confers rapamycin resistance in human breast cancer cells.
Chen Y; Zheng Y; Foster DA
Oncogene; 2003 Jun; 22(25):3937-42. PubMed ID: 12813467
[TBL] [Abstract][Full Text] [Related]
3. Alternative phospholipase D/mTOR survival signal in human breast cancer cells.
Chen Y; Rodrik V; Foster DA
Oncogene; 2005 Jan; 24(4):672-9. PubMed ID: 15580312
[TBL] [Abstract][Full Text] [Related]
4. Defective TGF-beta signaling sensitizes human cancer cells to rapamycin.
Gadir N; Jackson DN; Lee E; Foster DA
Oncogene; 2008 Feb; 27(8):1055-62. PubMed ID: 17700525
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
Ravitz MJ; Wenner CE
Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
[TBL] [Abstract][Full Text] [Related]
7. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
8. mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells.
Hui L; Rodrik V; Pielak RM; Knirr S; Zheng Y; Foster DA
J Biol Chem; 2005 Oct; 280(43):35829-35. PubMed ID: 16109716
[TBL] [Abstract][Full Text] [Related]
9. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions.
Mori S; Matsuzaki K; Yoshida K; Furukawa F; Tahashi Y; Yamagata H; Sekimoto G; Seki T; Matsui H; Nishizawa M; Fujisawa J; Okazaki K
Oncogene; 2004 Sep; 23(44):7416-29. PubMed ID: 15326485
[TBL] [Abstract][Full Text] [Related]
11. Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
Rodrik V; Zheng Y; Harrow F; Chen Y; Foster DA
Mol Cell Biol; 2005 Sep; 25(17):7917-25. PubMed ID: 16107734
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
[TBL] [Abstract][Full Text] [Related]
13. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
Ohmori T; Yang JL; Price JO; Arteaga CL
Exp Cell Res; 1998 Dec; 245(2):350-9. PubMed ID: 9851876
[TBL] [Abstract][Full Text] [Related]
14. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D.
Hui L; Zheng Y; Yan Y; Bargonetti J; Foster DA
Oncogene; 2006 Nov; 25(55):7305-10. PubMed ID: 16785993
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras.
Shi M; Zheng Y; Garcia A; Xu L; Foster DA
Cancer Lett; 2007 Dec; 258(2):268-75. PubMed ID: 17949898
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer Cells.
Hu X; Washington S; Verderame MF; Manni A
Cancer Res; 2005 Dec; 65(23):11026-33. PubMed ID: 16322252
[TBL] [Abstract][Full Text] [Related]
18. The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling.
Nyati S; Schinske-Sebolt K; Pitchiaya S; Chekhovskiy K; Chator A; Chaudhry N; Dosch J; Van Dort ME; Varambally S; Kumar-Sinha C; Nyati MK; Ray D; Walter NG; Yu H; Ross BD; Rehemtulla A
Sci Signal; 2015 Jan; 8(358):ra1. PubMed ID: 25564677
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]